| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |